Lidocaine Ointment USP — Class II drug recall D-0107-2027
Ongoing recall by Direct Rx, reported 2026-11-04, distributed nationwide. Subpotent Drug
| Recall number | D-0107-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Direct Rx, Dawsonville, GA, United States |
| Recall initiated | 2026-09-29 |
| Classified | 2026-10-29 |
| Reported by FDA | 2026-11-04 |
| Distributed | Nationwide (US) |
| Quantity | 493 jars |
| Reason classes | potency |
| NDC | 72189-0211-50 |
| Lot numbers | 03AP2511, 18JU2519, 18JU2520, 30AP2518 |
| Expiration dates | 2027-04-30 |
Product
Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0107-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.